Chlordiazepoxide Hydrochloride/clidinium Bromide
Product Images NDC 50090-0131

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride/clidinium Bromide (NDC 50090-0131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chlordiazepoxide 01)

Chemical structure of chlordiazepoxide hydrochloride, showing its molecular arrangement including a chlorinated benzodiazepine ring and hydrochloride component.*

FDA Label Image

Chemical Structure (Chlordiazepoxide 02)

Chemical structure of Chlordiazepoxide Hydrochloride/Clidinium Bromide, showing the molecular arrangement with bromine (Br) and complex ring groups, as associated with this combination drug product by A-S Medication Solutions.*

FDA Label Image

Label Image (Lbl500900131)

Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules, 5 mg/2.5 mg, labeled by A-S Medication Solutions. The label shows dosage strength, storage instructions at 77 degrees Fahrenheit, and package size of 30 capsules. The package includes the NDC 50090-0131 and dosing information on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.